Older breast cancer patients see more complications with brachytherapy

October 22, 2012

heralded for its low complication rates—actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical Oncology.

The standard treatment for older women with early stage breast cancer includes breast-conserving surgery, typically followed by radiation therapy to reduce the risk of . Rather than irradiating larger areas of the breast, as in whole breast irradiation, brachytherapy temporarily implants radiation sources in catheters within the surgical site. This technique delivers larger and fewer directly to the , which results in a shortened treatment time and, proponents of the therapy believe, decreased toxicity to surrounding healthy tissue.

"This treatment method seems ideal in theory, but we found it concerning that such an important clinical decision that affects so many women was being made on the basis of theory, rather than scientific evidence," said the study's lead author Cary P. Gross, M.D., associate professor of internal medicine at Yale School of Medicine. "Despite the absence of large comparing these two treatments, brachytherapy has become increasingly popular, in part because of a theoretically lower rate of complications."

To test the theory, Gross' team studied a national sample of approximately 30,000 women with and found that 15.8% of women undergoing radiation therapy received brachytherapy in 2008-2009, up from less than 1% in 2000 and 10% in 2006. There was substantial variation in brachytherapy use across the country, ranging from less than 5% of patients in some areas to over 70% in others.

The team found that the use of brachytherapy was associated with a 16.9% higher rate of wound and skin complications in the year after treatment compared to whole breast irradiation. There was no significant difference in the rate of deep tissue or bone complications between the two treatments.

"This study highlights the importance of conducting comparative effectiveness research before a new treatment becomes widespread," said Gross, who is co-director of the Robert Wood Johnson Clinical Scholars Program at Yale. "Medicare is spending significantly more money to cover this treatment, which potentially exposes women to a higher risk of complications than the 'tried and true' whole ."

Explore further: Radiation still used despite evidence of little benefit to some older breast cancer patients

Related Stories

Radiation still used despite evidence of little benefit to some older breast cancer patients

March 5, 2012
Even though a large clinical study demonstrated that radiation has limited benefit in treating breast cancer in some older women, there was little change in the use of radiation among older women in the Medicare program, ...

APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation

May 1, 2012
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate ...

Study finds side effects, complications, mastectomy more likely after partial breast irradiation

December 7, 2011
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.